Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-02-05Clinical Trial Update: Study to Compare the Efficacy and Safety of CELBESTA® and CELEBREX® in Patients With Rheumatoid Arthritis [Phase 4]
Phase 4 clinical trial comparing CELBESTA and CELEBREX in rheumatoid arthritis has completed.
-
FDA approval · 2020-02-04FDA Approved: LEFLUNOMIDE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved the original application for Leflunomide from Lupin Pharmaceuticals, establishing a generic version of the drug.
-
FDA approval · 2020-01-30FDA Approved: METHOTREXATE — Original Application (Chartwell RX, LLC)
FDA approvedChartwell RX, LLC's methotrexate product under an Original Application, making a new generic version of methotrexate available. …
-
CLINICAL_TRIALS trial_result · 2020-01-30Clinical Trial Update: Donepezil Attenuate Postoperative Cognitive Dysfunction [Phase 3]
Phase 3 trial update exploring donepezil to attenuate postoperative cognitive dysfunction.
-
CLINICAL_TRIALS trial_result · 2020-01-29Clinical Trial Update: A Study of RO7123520 to Evaluate the Safety and Efficacy in Participants With Moderately To Severely Active Rheumatoid Arthritis (RA) Who Are Inadequately Responding to Anti-Tumor Necrosis Factor (TNF)-Alpha Therapy [Phase 2]
Phase 2 trial of RO7123520 in moderately to severely active rheumatoid arthritis that terminated; results posted in 2020.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-01-22Clinical Trial Update: An Open-Label Study to Assess the Rate of Failure of an Enbrel® (Etanercept) SureClick™ Auto-injector in Subjects With Rheumatoid Arthritis [Phase 4]
An open-label Phase 4 study evaluating the failure rate of the Enbrel SureClick auto-injector in adults with rheumatoid arthritis.
-
CLINICAL_TRIALS research · 2020-01-18Clinical Trial Update: Enhancing Patient Ability to Understand and Utilize Complex Information Concerning Medication Self-management [NA]
A completed ClinicalTrials.gov study focused on enhancing patient understanding and use of information for medication self-management in rhe…
-
CLINICAL_TRIALS trial_result · 2020-01-13Clinical Trial Update: Comparative Pharmacokinetic, Pharmacodynamic, Safety and Efficacy Study of Three Anti-CD20 Monoclonal Antibodies in Patients With Moderate to Severe Rheumatoid Arthritis [Phase 1, Phase 2]
A comparative pharmacokinetic, pharmacodynamic, safety and efficacy study of three anti-CD20 monoclonal antibodies in patients with moderate…
-
CLINICAL_TRIALS trial_result · 2020-01-13Clinical Trial Update: Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Rheumatoid Diseases Who Are Naïve To Biologics Or Switched From Remicade
A completed clinical trial evaluating post-marketing use of CT-P13 (infliximab) for standard care in patients with rheumatoid diseases who a…
-
CLINICAL_TRIALS trial_result · 2020-01-02Clinical Trial Update: T Cells and TNF (Tumor Necrosis Factor): The Impact of TNF Blockade
Clinical trial update on T cells and TNF blockade in inflammatory diseases; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-12-30Clinical Trial Update: A Study Evaluating the Efficacy and Safety of CKD-506 in Adult Subjects With Moderate-to-Severe Rheumatoid Arthritis and Inadequate Response to Methotrexate [Phase 2]
Phase 2 study evaluating CKD-506 for efficacy and safety in adults with moderate-to-severe rheumatoid arthritis who did not respond to metho…
-
FDA label_change · 2019-12-26FDA Approved: OTREXUP — Supplemental Application (Antares Pharma, Inc.)
FDA approved a supplemental application for OTREXUP (methotrexate) from Antares Pharma, Inc., leading to changes in the labeling for this su…
-
CLINICAL_TRIALS trial_result · 2019-12-26Clinical Trial Update: Cobiprostone Prevention of NSAID-induced Gastroduodenal Injury [Phase 2]
Phase 2 trial of cobiprostone for prevention of NSAID-induced gastroduodenal injury completed with posted results.
-
FDA approval · 2019-12-23FDA Approved: PIROXICAM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's supplemental application for Piroxicam (PIROXICAM). This is a supplemental approval affecting the PIROXICAM product.
-
FDA approval · 2019-12-23FDA Approved: PENICILLAMINE — Original Application (Endo USA, Inc.)
The FDA approved Endo USA, Inc.'s generic penicillamine. The generic is approved for the treatment of Wilson disease and rheumatoid arthriti…
-
CLINICAL_TRIALS research · 2019-12-17Clinical Trial Update: Serum Calprotectin Level in Patients With Rheumatoid Arthritis and Osteoarthritis [Phase 4]
Phase 4 clinical trial update evaluating serum calprotectin levels in patients with rheumatoid arthritis and osteoarthritis.
-
CLINICAL_TRIALS trial_result · 2019-12-13Clinical Trial Update: AMG 162 (Denosumab) Phase 3 Study (DESIRABLE Study) in Participants With Rheumatoid Arthritis on Disease-modifying Antirheumatic Drugs (DMARDs) Treatment [NA]
Phase 3 DESIRABLE study evaluating denosumab (AMG 162) in participants with rheumatoid arthritis on DMARDs has completed with results posted…
-
FDA approval · 2019-12-12FDA Approved: XELJANZ XR — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for XELJANZ XR (tofacitinib) from Pfizer Laboratories Div Pfizer Inc, indicating an update to the pr…
-
CLINICAL_TRIALS trial_result · 2019-12-10Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of SM03 in Patients With Rheumatoid Arthritis Receiving Methotrexate [Phase 2]
Phase 2 clinical trial evaluating safety and efficacy of SM03 in rheumatoid arthritis patients on methotrexate has completed.
-
FDA approval · 2019-12-06FDA Approved: AVSOLA — Original Application (Amgen, Inc)
FDA approved AVSOLA (infliximab-axxq) from Amgen as a biosimilar to infliximab, for the same indications as the reference product.
-
CLINICAL_TRIALS trial_result · 2019-12-04Clinical Trial Update: Methotrexate Withdrawal Study of Tofacitinib Modified Release Formulation in Subjects With Rheumatoid Arthritis [Phase 4]
Phase 4 trial update on methotrexate withdrawal in rheumatoid arthritis patients treated with tofacitinib modified-release formulation; resu…
-
FDA approval · 2019-12-03FDA Approved: DICLOFENAC POTASSIUM — Original Application (Lifsa Drugs LLC)
FDA approved the original application for diclofenac potassium as a generic NSAID for relief of pain and inflammation associated with variou…
-
FDA approval · 2019-12-02FDA Approved: MELOXICAM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for meloxicam by Aurobindo Pharma Limited. The approval covers changes approved under this supplemen…
-
CLINICAL_TRIALS trial_result · 2019-11-27Clinical Trial Update: Clinical Comparative Study to Evaluate the Efficacy and Safety of Recombinant Anti-TNF-alpha Antibodies for Injection [Phase 3]
Phase 3 clinical trial update evaluating recombinant anti-TNF-alpha antibodies for rheumatoid arthritis; current status unknown.
-
FDA approval · 2019-11-27FDA Approved: CELECOXIB — Original Application (NIVAGEN PHARMACEUTICALS, INC.)
The FDA approved NIVAGEN Pharmaceuticals, Inc.'s original application for a generic celecoxib product.